Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Canada (Primary) | PRIMARYCAN | Univ | 1,733 | 2,734,961 | 0.37% | 0.89% | 2.86% | 11.41% | 11.84% | 24.69% |
Healthcare | HEALTHCARE | Sector | 76 | 9,581 | -0.48% | -1.78% | 2.06% | 7.24% | 2.05% | 17.44% |
Biopharmaceuticals | BIOPHARMA | SubSec | 26 | 2,269 | -0.63% | -3.01% | 3.61% | 7.12% | 6.25% | -11.78% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 11 | 1,065 | -1.82% | -4.87% | 5.58% | 10.83% | 9.01% | 16.54% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Endocrinology and Metabolism Biopharmaceuticals | ENDOCRINOLOGY | SubInd | 3 | 200 | -0.23% | -0.35% | 26.55% | 10.85% | 58.89% | 58.89% |
Musculoskeletal System Biopharmaceuticals | MUSCULOSKELETAL | SubInd | 1 | 181 | -2.00% | -6.28% | 16.05% | 28.65% | 40.49% | 31.46% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 11 | 1,065 | -1.82% | -4.87% | 5.58% | 10.83% | 9.01% | 16.54% |
S&P/TSX Capped Composite | XIC:CANXIC:CAN | Benchmark | 213 | 3,275,261 | 0.21% | 1.16% | 3.51% | 12.57% | 9.63% | 23.05% |
Cardiovascular System Biopharmaceuticals | CARDIOVASCULAR | SubInd | 2 | 60 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 1 | 16 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 3 | 374 | -4.26% | -9.32% | -2.70% | 2.86% | 5.39% | 15.92% |
Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 1 | 233 | -0.56% | -2.53% | -4.26% | -0.40% | -10.25% | 1.81% |
* Colors indicate performance relative to the benchmark.